Which company will acquire ‘Mercilon’ this November?
The whereabouts of ‘Mercilon,’ a Bayer’s oral contraceptive, which will be decided within this month, has attracted attention.
As pointed out for the Substantial Lessening of Competition by the Fair Trade Commission(FTC), if taking over MSD Korea’s OTC drugs, Bayer Korea was ordered to sell the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
